Global Information
회사소개 | 문의 | 비교리스트

세계의 백신 및 의약품 시장 : COVID-19의 영향을 감안한 종류, 최종 용도 및 지역별 예측

Global Vaccine and Drugs Market Size study with COVID-19 Impact, by Type (Vaccine, Drugs) by End-Use (Hospitals, Clinics, Others) and Regional Forecasts 2020-2026

리서치사 Bizwit Research & Consulting LLP
발행일 2020년 05월 상품 코드 939857
페이지 정보 영문
가격
US $ 4,950 ₩ 5,667,000 Unprintable PDF by E-mail (Single User License)
US $ 6,250 ₩ 7,155,000 Printable PDF by E-mail (Enterprise License)


세계의 백신 및 의약품 시장 : COVID-19의 영향을 감안한 종류, 최종 용도 및 지역별 예측 Global Vaccine and Drugs Market Size study with COVID-19 Impact, by Type (Vaccine, Drugs) by End-Use (Hospitals, Clinics, Others) and Regional Forecasts 2020-2026
발행일 : 2020년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 백신 및 의약품(Vaccine and Drugs) 시장을 조사했으며, 전체적인 시장 동향, 부문별 상세 동향, 시장 성장에 대한 영향요인 분석, 경쟁 상황, 주요 기업 개요 등을 종합적으로 정리했습니다.

목차

제1장 주요 요약

제2장 세계의 백신 및 의약품 시장 정의와 범위

제3장 세계의 백신 및 의약품 시장 역학

  • 백신 및 의약품 시장 영향 분석

제4장 세계의 백신 및 의약품 시장 : 업계 분석

  • Porter's 5 Force 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 제안과 결론

제5장 종류별 세계의 백신 및 의약품 시장

  • 시장 현황
  • 종류별 시장 실적 - 잠재력 분석
  • 종류별 시장 추정·예측(10억 달러)
  • 백신 및 의약품 시장, 하위 부문 분석
    • 백신
    • 의약품

제6장 최종사용자별 세계의 백신 및 의약품 시장

  • 시장 현황
  • 최종사용자별 시장 실적 - 잠재력 분석
  • 최종사용자별 시장 추정·예측(10억 달러)
  • 백신 및 의약품 시장, 하위 부문 분석
    • 병원
    • 클리닉
    • 기타

제7장 세계의 백신 및 의약품 시장, 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 지역

제8장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Pfizer Inc.(미국)
    • Johnson & Johnson Services Inc(미국)
    • GlaxoSmithKline plc.(영국)
    • Sanofi S.A(프랑스)
    • Serum Institute of India(인도)
    • Gilead Sciences Inc.(미국)
    • F. Hoffmann-La Roche Ltd(스위스)
    • Merck KGaA(독일)
    • Janssen Pharmaceuticals, Inc.(벨기에)

제9장 조사 방법

KSM 20.06.19

LIST OF TABLES

  • TABLE 1. List of secondary sources, used in the study of global Vaccine and Drugs market
  • TABLE 2. List of primary sources, used in the study of global Vaccine and Drugs market
  • TABLE 3. Global Vaccine and Drugs market, report scope
  • TABLE 4. Years considered for the study
  • TABLE 5. Exchange rates considered
  • TABLE 6. Global Vaccine and Drugs market estimates & forecasts by region 2016-2026 (USD billion)
  • TABLE 7. Global Vaccine and Drugs market estimates & forecasts by type 2016-2026 (USD billion)
  • TABLE 8. Global Vaccine and Drugs market estimates & forecasts by end-user 2016-2026 (USD billion)
  • TABLE 9. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 10. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 11. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 12. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 13. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 14. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 15. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 16. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 17. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 18. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 19. U.S. Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 20. U.S. Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 21. U.S. Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 22. Canada Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 23. Canada Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 24. Canada Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 25. UK Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 26. UK Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 27. UK Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 28. Germany Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 29. Germany Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 30. Germany Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 31. RoE Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 32. RoE Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 33. RoE Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 34. China Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 35. China Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 36. China Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 37. India Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 38. India Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 39. India Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 40. Japan Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 41. Japan Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 42. Japan Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 43. RoAPAC Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 44. RoAPAC Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 45. RoAPAC Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 46. Brazil Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 47. Brazil Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 48. Brazil Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 49. Mexico Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 50. Mexico Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 51. Mexico Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 52. RoLA Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 53. RoLA Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 54. RoLA Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 55. RoW Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 56. RoW Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 57. RoW Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)

LIST OF FIGURES

  • FIG 1. Global Vaccine and Drugs market, research methodology
  • FIG 2. Global Vaccine and Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Vaccine and Drugs market, key trends 2019
  • FIG 5. Global Vaccine and Drugs market, growth prospects 2020-2026
  • FIG 6. Global Vaccine and Drugs market, porters 5 force model
  • FIG 7. Global Vaccine and Drugs market, pest analysis
  • FIG 8. Global Vaccine and Drugs market, value chain analysis
  • FIG 9. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 10. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 11. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 12. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 13. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 14. Global Vaccine and Drugs market, regional snapshot 2016 & 2026
  • FIG 15. North America Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 16. Europe Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 17. Asia pacific Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 18. Latin America Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 19. Global Vaccine and Drugs market, company market share analysis (2019)

Global Vaccine and Drugs Market is valued approximately at USD XXX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2020-2026. Vaccines are doses of killed microbes which stimulate the immune systems of the body against that particular microbe, preventing the diseases As the dead microbes of the disease are injected, the body develops resistance towards that particular type of microbe thus preventing the disease when the live microbes attack the human and boosting the immune system and Drugs are the compounds which change the functioning of the consumer when inhaled. Thus, both Vaccines and Drugs are used to prevent and treat diseases. The increase in number of infectious diseases across the globe including Swine Flu, Ebola, Influenza, Tuberculosis, hepatitis and more drive the market for Vaccines and Drugs. These infectious diseases transmit quickly and hence vaccines are required to immunize the population. For Instance: the spread of the COVID-19 virus has steered the vaccine and drug market towards growth. With the disease declared as a pandemic the requirement for its Vaccine and drugs has soared. This is due to the large population being infected by the virus which increases the demand for treatment drugs. As per the World of Meters, as of 6th may 2020, there were around 3.7 million cases of COVID-19 across the globe. The treatment of these huge number of infected people brings a steep incline in the vaccine and drugs market. Due to these treatment efforts, 1.2 million people have been cured. Moreover, to save the rest of the population of the world from the novel Corona Virus, the development of a Vaccine is essential. This has led to increased investments and efforts in the research and development department of the medical sector. Laboratories across the globe are working on developing a vaccine for the virus which has boosted the Vaccine market. As the increasing number of clinical trials propels an increase in the vaccine and drugs market. As of 17th April 2020, the national Medical Products Administration of China approved Two COVID-19 inactivated vaccines for a phase 1 and 2 combined trial. Moreover, in March 2020, two major pharma companies, Pfizer and BioNTech announced a joint venture to co-develop and distribute coronavirus vaccine. Also, in April 2020, Johnson & Johnson announced to produce to 900 million COVID-19 vaccine by the first quarter of 2021.Hence the spread of the pandemic has stimulated share activity in the vaccine and drug market leading to its growth. However, Stringent regulations and Lengthy approval procedure impedes the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Vaccine and Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of major pharma companies in the region which have the resources to develop the vaccine. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising populations and growing number of cases along with early clinical trial approvals would create lucrative growth prospects for the Vaccine and Drugs market across Asia-Pacific region.

Major market player included in this report are:

  • Pfizer Inc. (US)
  • Johnson & Johnson Services Inc (US)
  • GlaxoSmithKline plc. (UK)
  • Sanofi S.A (France)
  • Serum Institute of India (India)
  • Gilead Sciences Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck KGaA (Germany)
  • Janssen Pharmaceuticals, Inc. (Belgium)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Vaccine
  • Drugs

By End-use:

  • Hospitals
  • Clinicals
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017, 2018
  • Base year - 20198
  • Forecast period - 2020 to 2026

Target Audience of the Global Vaccine and Drugs Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Vaccine and Drugs Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Vaccine and Drugs Market, by Type, 2018-2026 (USD Billion)
    • 1.2.3. Vaccine and Drugs Market, by End-User, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vaccine and Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vaccine and Drugs Market Dynamics

  • 3.1. Vaccine and Drugs Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Vaccine and Drugs Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Vaccine and Drugs Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Vaccine and Drugs Market by Type, Performance - Potential Analysis
  • 5.3. Global Vaccine and Drugs Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Vaccine and Drugs Market, Sub Segment Analysis
    • 5.4.1. Vaccine
    • 5.4.2. Drugs

Chapter 6. Global Vaccine and Drugs Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Vaccine and Drugs Market by End-User, Performance - Potential Analysis
  • 6.3. Global Vaccine and Drugs Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
  • 6.4. Vaccine and Drugs Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Others

Chapter 7. Global Vaccine and Drugs Market, Regional Analysis

  • 7.1. Vaccine and Drugs Market, Regional Market Snapshot
  • 7.2. North America Vaccine and Drugs Market
    • 7.2.1. U.S. Vaccine and Drugs Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. End-User breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Vaccine and Drugs Market
  • 7.3. Europe Vaccine and Drugs Market Snapshot
    • 7.3.1. U.K. Vaccine and Drugs Market
    • 7.3.2. Germany Vaccine and Drugs Market
    • 7.3.3. Rest of Europe Vaccine and Drugs Market
  • 7.4. Asia-Pacific Vaccine and Drugs Market Snapshot
    • 7.4.1. China Vaccine and Drugs Market
    • 7.4.2. India Vaccine and Drugs Market
    • 7.4.3. Japan Vaccine and Drugs Market
    • 7.4.4. Rest of Asia Pacific Vaccine and Drugs Market
  • 7.5. Latin America Vaccine and Drugs Market Snapshot
    • 7.5.1. Brazil Vaccine and Drugs Market
    • 7.5.2. Mexico Vaccine and Drugs Market
  • 7.6. Rest of The World Vaccine and Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Pfizer Inc. (US)
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Johnson & Johnson Services Inc (US)
    • 8.2.3. GlaxoSmithKline plc. (UK)
    • 8.2.4. Sanofi S.A (France)
    • 8.2.5. Serum Institute of India (India)
    • 8.2.6. Gilead Sciences Inc. (US)
    • 8.2.7. F. Hoffmann-La Roche Ltd (Switzerland)
    • 8.2.8. Merck KGaA (Germany)
    • 8.2.9. Janssen Pharmaceuticals, Inc. (Belgium)

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
Back to Top
전화 문의
F A Q